Resistant Hypertension - Causes Consequences and Novel Therapeutic Approaches

Status	Finished
Effective start/end date	1/01/15 → 31/12/20

Access Project

Renal denervation in combination with angiotensin receptor blockade prolongs blood pressure trough during hemorrhage
Singh, R. R., McArdle, Z., Booth, L. C., May, C. N., Head, G. A., Moritz, K. M., Schlaich, M. P. & Denton, K. M., 1 Jan 2022, In: Hypertension. 79, 1, p. 261-270 10 p.
Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus)
Combined renal and common hepatic artery denervation as a novel approach to reduce cardiometabolic risk: technical approach, feasibility and safety in a pre-clinical model
Kiuchi, M. G., Ganesan, K., Keating, J., Carnagarin, R., Matthews, V. B., Herat, L. Y., Goh, G., Adams, L. & Schlaich, M. P., May 2021, In: Clinical Research in Cardiology. 110, 5, p. 740-753 14 p.
Research output: Contribution to journal › Article › peer-review

Open Access
10 Citations (Scopus)
Ultra-low-dose quadruple combination blood pressure-lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol
Chow, C. K., Atkins, E. R., Billot, L., Chalmers, J., Hillis, G. S., Hay, P., Neal, B., Nelson, M., Patel, A., Reid, C. M., Schlaich, M., Usherwood, T., Webster, R. & Rodgers, A., Jan 2021, In: American Heart Journal. 231, p. 56-67 12 p.
Research output: Contribution to journal › Article › peer-review

Open Access
16 Citations (Scopus)